Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

etiprednol dicloacetate

Known as: ethyl-17alpha-dichloroacetoxy-11beta-hydroxyandrosta-1,4-diene-3-one-17beta-carboxylate 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Loteprednol etabonate (LE) is the first, highly successful soft corticosteroid (SC) designed using the ‘inactive metabolite… 
2017
2017
Graphical abstract Figure. No Caption available. ABSTRACT The soft drug approach is successful in obtaining high local… 
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Review
2008
Review
2008
Despite its apparent easy accessibility, the eye is, in fact, well protected against the absorption of foreign materials… 
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Review
2006
Review
2006
Inhaled and intranasal corticosteroids (ICSs) still are the most effective treatment available for allergic airway diseases and… 
2004
2004
In vitro and in vivo anti-inflammatory properties and soft characteristics of etiprednol dicloacetate (BNP-166) a new steroid… 
2004
2004
Etiprednol dicloacetate (ethyl 17alpha-dichloroacetoxy-11beta-hydroxy-androsta-1,4-diene-3-one-17beta-carboxylate, code-named… 
2004
2004
During development of chemistry of the soft drug candidate etiprednol dicloacetate (BNP-166) 1) optimization studies on the three… 
2003
2003
In the present study, the pharmacological effects of etiprednol dicloacetate (BNP-166; ethyl-17α-dichloroacetoxy-11… 
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
2003
2003
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the…